Muscular Dystrophy, Duchenne
DBCAT005549Pharmacologic class
A DrugBank category of 2 drugs. 1 of them is approved.
What you can answer from here — as of January 08, 2022
Which targets do Muscular Dystrophy, Duchenne share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account